| Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance L Chang, PH Graham, J Hao, J Ni, J Bucci, PJ Cozzi, JH Kearsley, Y Li Cell death & disease 4 (10), e875-e875, 2013 | 409 | 2013 |
| PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair … L Chang, PH Graham, J Hao, J Ni, J Bucci, PJ Cozzi, JH Kearsley, Y Li Cell death & disease 5 (10), e1437-e1437, 2014 | 331 | 2014 |
| Cancer stem cell in breast cancer therapeutic resistance X Bai, J Ni, J Beretov, P Graham, Y Li Cancer treatment reviews 69, 152-163, 2018 | 302 | 2018 |
| Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell … J Deng, X Bai, X Feng, J Ni, J Beretov, P Graham, Y Li BMC cancer 19, 1-12, 2019 | 228 | 2019 |
| Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway J Ni, P Cozzi, J Hao, J Beretov, L Chang, W Duan, S Shigdar, W Delprado, ... The international journal of biochemistry & cell biology 45 (12), 2736-2748, 2013 | 212 | 2013 |
| Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance L Chang, PH Graham, J Ni, J Hao, J Bucci, PJ Cozzi, Y Li Critical reviews in oncology/hematology 96 (3), 507-517, 2015 | 198 | 2015 |
| Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis B Pang, Y Zhu, J Ni, J Thompson, D Malouf, J Bucci, P Graham, Y Li Theranostics 10 (5), 2309, 2020 | 182 | 2020 |
| CD44 variant 6 is associated with prostate cancer metastasis and chemo‐/radioresistance J Ni, PJ Cozzi, JL Hao, J Beretov, L Chang, W Duan, S Shigdar, ... The Prostate 74 (6), 602-617, 2014 | 172 | 2014 |
| Cancer stem cells and signaling pathways in radioresistance L Chang, P Graham, J Hao, J Ni, J Deng, J Bucci, D Malouf, D Gillatt, Y Li Oncotarget 7 (10), 11002, 2015 | 126 | 2015 |
| Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer J Deng, L Wang, H Chen, J Hao, J Ni, L Chang, W Duan, P Graham, Y Li Oncotarget 7 (34), 55771, 2016 | 108 | 2016 |
| Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer J Wang, J Ni, J Beretov, J Thompson, P Graham, Y Li Critical reviews in oncology/hematology 145, 102860, 2020 | 102 | 2020 |
| The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression J Deng, L Wang, H Chen, L Li, Y Ma, J Ni, Y Li Cancer and Metastasis Reviews 32, 535-551, 2013 | 101 | 2013 |
| Role of the EpCAM (CD326) in prostate cancer metastasis and progression J Ni, PJ Cozzi, W Duan, S Shigdar, PH Graham, KH John, Y Li Cancer and Metastasis Reviews 31, 779-791, 2012 | 94 | 2012 |
| Urinary biomarkers in prostate cancer detection and monitoring progression D Wu, J Ni, J Beretov, P Cozzi, M Willcox, V Wasinger, B Walsh, ... Critical reviews in oncology/hematology 118, 15-26, 2017 | 90 | 2017 |
| Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression L Chang, J Ni, Y Zhu, B Pang, P Graham, H Zhang, Y Li Theranostics 9 (14), 4130, 2019 | 82 | 2019 |
| Exosomes in cancer radioresistance J Ni, J Bucci, D Malouf, M Knox, P Graham, Y Li Frontiers in oncology 9, 869, 2019 | 81 | 2019 |
| Cancer stem cells in prostate cancer chemoresistance J Ni, P Cozzi, J Hao, W Duan, P Graham, J Kearsley, Y Li Current cancer drug targets 14 (3), 225-240, 2014 | 75 | 2014 |
| Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach L Chang, J Ni, J Beretov, VC Wasinger, J Hao, J Bucci, D Malouf, D Gillatt, ... Scientific Reports 7 (1), 41834, 2017 | 73 | 2017 |
| Targeting microRNAs in prostate cancer radiotherapy J Ni, J Bucci, L Chang, D Malouf, P Graham, Y Li Theranostics 7 (13), 3243, 2017 | 72 | 2017 |
| Cancer stem cells in prostate cancer radioresistance T Tsao, J Beretov, J Ni, X Bai, J Bucci, P Graham, Y Li Cancer letters 465, 94-104, 2019 | 68 | 2019 |
